Coloplast A/S (CPH: COLO.B)
Denmark flag Denmark · Delayed Price · Currency is DKK
797.20
+6.80 (0.86%)
Dec 20, 2024, 4:59 PM CET

Coloplast Revenue

In the fiscal year ending September 30, 2024, Coloplast had annual revenue of 27.03B DKK with 10.33% growth. Coloplast had revenue of 6.95B in the quarter ending September 30, 2024, with 11.68% growth.

Revenue
27.03B
Revenue Growth
+10.33%
P/S Ratio
6.63
Revenue / Employee
1.62M
Employees
16,639
Market Cap
179.48B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Sep 30, 202427.03B2.53B10.33%
Sep 30, 202324.50B1.92B8.51%
Sep 30, 202222.58B3.15B16.23%
Sep 30, 202119.43B882.00M4.76%
Sep 30, 202018.54B605.00M3.37%
Sep 30, 2019 Pro Pro Pro
Sep 30, 2018 Pro Pro Pro
Sep 30, 2017 Pro Pro Pro
Sep 30, 2016 Pro Pro Pro
Sep 30, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Novo Nordisk A/S 270.58B
Genmab A/S 19.84B
Demant A/S 22.84B
Zealand Pharma A/S 76.87M
H. Lundbeck A/S 21.44B
H. Lundbeck A/S 21.44B
ALK-Abelló A/S 5.38B
Ambu A/S 5.39B
Revenue Rankings